Family · Pharmaceutical analytical standards
Nalmefene
An opioid receptor modulator derived from naltrexone: approved in the United States in 1995 to reverse the effects of opioids, and in Europe in 2013 to reduce alcohol consumption in people with alcohol dependence. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It differs from naltrexone by a single chemical detail: in place of a double-bonded oxygen atom (a ketone group) it carries a methylene group, =CH2.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
